Mechanisms for induction of autoimmunity in humans

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 87, Issue 424, 1998, Pages 16-20

  Moller E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoimmunity; HLA associated disease; Idiopathic thrombocytopenic purpura; Virus induced immunity

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; HLA SYSTEM; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOGENETICS; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 0031692789     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1998.tb01228.x     Document Type: Article

References (27)

1. Möller E, Böhme J, Valugerdi M, Ridderstad A, Olerup O. Speculations on mechanisms of HLA associations with autoimmune diseases and the specificity of "autoreactive" T lymphocytes. Immunol Rev 1990; 118: 5
2. Möller G, editor. Viruses and autoimmunity. Immunol Rev 1996; 152
3. Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, Odermatt B, et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice Cell 1991; 65: 305
4. Oldstone MB, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991; 65: 319
5. van Herrath M, Guerder S, Lewicki H, Flavell R, Oldstone M. Coexpression of B7-1 and viral ("self") transgenes in pancreatic β cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 1995; 3: 727
6. Fujinami RS, Oldstone MBA. Amino acid homology between encephalitogenic site of myelin basic protein and virus: a mechanism for autoimmunity. Science 1985; 230: 1043
7. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell mediated autoimmunity. Viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695
8. Chen Y, Inobe J-I, Marks R, Gonella P, Kuchroo VK, Weiner H. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376: 177
9. Conrad B, Waldmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994; 371: 351
10. Speir ER, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391
11. Farrell HE, Vally DM, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 1997; 386: 510
12. Reyburn HT, Mandelboim O, Valés-Gómez M, Davis DM, Pazmany L, Strominger JL. The class I MHC homologue of human cytomegalvorius inhibits attack by natural killer cells. Nature 1997; 386: 514
13. Wiertz EJHJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 1996; 84: 769
14. Gilbert MJ, Riddell SR, Plachter B, Greenberg PD. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature 1996; 383: 720
15. Söderberg C, Giugni TD, Zaia JA, Larsson S, Wahlberg JM, Möller E. CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol 1993; 67: 6576
16. Giugni TD, Söderberg C, Ham DJ, Bautista RM, Hedlund KO, Möller E, Zaia JA. Neutralization of human cytomegalovirus by human CD13-specific antibodies. J Infect Dis 1996; 173: 1062
17. Lodish HF, Porter M. Specific incorporation of host cell surface proteins into budding vesicular stomatitits virus. Cell 1980; 19: 161
18. Söderberg C, Hultenby K, Fish K. Selective incorporation of host cell proteins in the envelope of human cytomegalovirus during particle maturation. Manuscript
19. Söderberg C, Larsson S, Möller E. A novel mechanism for virus-induced autoimmunity in humans. Immunol Rev 1996; 152: 145
20. Söderberg C, Sumitran-Karuppan S, Ljungman P, Möller E. CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients. Transplantation 1996; 61: 594
21. Söderberg C, Larsson S, Lundh-Rozell BI, Sumitran-Karuppan S, Ljungman P, Möller E. Cytomegalovirus-induced CD13-specific autoimmunity - a possible cause of chronic graft-vs-host disease. Transplantation 1996; 61: 600
22. Kanayama N, Kajiwara Y, Goto J, Maradny EEL, Maehara K, Andou K, Terao T. Inactivation of interleukin-8 by aminopeptidase N (CD13). J Leucocyte Biol 1995; 57: 129
23. Larsen SL, Östergaard Pedersen L, Buus S, Stryhn A. T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatiblity complex class II-bound peptides. J Exp Med 1996; 184: 183
24. Xu Y, Wellner D, Scheinberg DA. Substance P and bradykinin are natural inhibitors of CD13/aminopeptidase N. Biochem Biophys Res Commun 1995; 208: 664
25. Weber M, Ugaccioni M, Baggiolini M, Clark-Lewis I, Dahinden CA. Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from activator of basophil mediator release to an eosinophil chemoattractant. J Exp Med 1996; 183: 681
26. Sakai I, Fujii H, Yoneda J, Fuminori A, Nakajima M, Tsuruo T, Azuma I. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 1993; 54: 137
27. Fujii H, Nakajima M, Saiki I, Yoneda J, Azuma I, Tsuruo T. Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13. Clin Exp Metastasis 1995; 13: 337